Science Explorer Back to mapMap
Discussion
University · Pisa · Italy

Abiogen Pharma (Italy)

abiogen.it/enROR OpenAlex
Research works
36
▼ 8% vs 2018-21
Citations
644
18.1 per fractional work
Top-10% rate
14.4%
all institutions 10.0%
Open access
52%
world 40%
International
30%
world 18%
Abiogen Pharma (Italy)

Not ranked overall: Abiogen Pharma (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Abiogen Pharma (Italy) work in?

In all years, 40% of research at Abiogen Pharma (Italy) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (35%), Biochemistry, Genetics and Molecular Biology (20%), Chemistry (19%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 14 fractional works · 39.8% of its workMedicine: 12 fractional works · 35.0% of its workPathology and Forensic Medicine: 1 fractional works · 3.8% of its workSurgery: 1 fractional works · 3.4% of its workOncology: 1 fractional works · 2.8% of its workDermatology: 1 fractional works · 2.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.7% of its workInfectious Diseases: 1 fractional works · 2.1% of its workEpidemiology: 1 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.7% of its workPharmacology: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.5% of its workNephrology: 0 fractional works · 1.3% of its workHematology: 0 fractional works · 1.2% of its workOrthopedics and Sports Medicine: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workRehabilitation: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 3.1% of its workNutrition and Dietetics: 1 fractional works · 3.1% of its workVeterinary: 0 fractional works · 1.3% of its workSmall Animals: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 11 fractional works · 29.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 20.3% of its workMolecular Biology: 4 fractional works · 12.4% of its workGenetics: 1 fractional works · 2.1% of its workBiotechnology: 1 fractional works · 2.0% of its workCell Biology: 1 fractional works · 1.5% of its workCancer Research: 0 fractional works · 0.7% of its workBiochemistry: 0 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 3.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 0.9% of its workSensory Systems: 0 fractional works · 0.9% of its workBiological Psychiatry: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 2.4% of its workFood Science: 0 fractional works · 1.2% of its workPlant Science: 0 fractional works · 0.7% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.7% of its workPharmaceutical Science: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 1 fractional works · 1.7% of its workImmunology: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysical Sciences: 10 fractional works · 28.6% of its workChemistry: 7 fractional works · 19.2% of its workOrganic Chemistry: 4 fractional works · 11.9% of its workSpectroscopy: 1 fractional works · 2.4% of its workElectrochemistry: 1 fractional works · 1.9% of its workPhysical and Theoretical Chemistry: 0 fractional works · 1.4% of its workInorganic Chemistry: 0 fractional works · 1.1% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workEngineering: 1 fractional works · 3.7% of its workBiomedical Engineering: 1 fractional works · 3.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 2.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.2% of its workEcology: 0 fractional works · 0.9% of its workEnvironmental Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 1.9% of its workBiomaterials: 0 fractional works · 0.8% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workSurfaces, Coatings and Films: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.5% of its workInformation Systems: 0 fractional works · 0.5% of its workEnergy: 0 fractional works · 0.5% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.5% of its workChemical Engineering: 0 fractional works · 0.3% of its workProcess Chemistry and Technology: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 1.8% of its workSocial Sciences: 0 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.8% of its workEconomics and Econometrics: 0 fractional works · 0.8% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKAbiogen Pharma(Italy)36fractional works, all years
Life Sciences30%Physical Sciences29%Health Sciences40%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1235.0%
    2. Nursing13.1%
    3. Veterinary01.3%
    4. Health Professions00.3%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology720.3%
    2. Neuroscience13.9%
    3. Agricultural and Biological Sciences12.4%
    4. Pharmacology, Toxicology and Pharmaceutics11.7%
    5. Immunology and Microbiology11.7%
    1. Chemistry719.2%
    2. Engineering13.7%
    3. Environmental Science12.4%
    4. Materials Science11.9%
    5. Computer Science00.5%
    6. Energy00.5%
    7. Chemical Engineering00.3%
    1. Social Sciences00.9%
    2. Economics, Econometrics and Finance00.8%
    3. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.61× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.54× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.68× its world share, 0 worksImmunology and Micro…Neuroscience: 1.76× its world share, 0 worksNeuroscienceChemistry: 3.19× its world share, 1 worksChemistryEngineering: 0.18× its world share, 0 worksEngineeringEnvironmental Science: 0.47× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.29× its world share, 0 worksMaterials ScienceHealth Professions: 0.38× its world share, 0 worksHealth ProfessionsMedicine: 2.97× its world share, 6 worksMedicineNursing: 6.33× its world share, 0 worksNursingBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.17× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.23× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 6.3×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Nursing6.33×0 works
  2. Chemistry3.19×1 works
  3. Medicine2.97×6 works
  4. Immunology and Microbiology2.68×0 works
  5. Biochemistry, Genetics and Molecular Biology2.54×2 works
  6. Neuroscience1.76×0 works
  7. Economics, Econometrics and Finance1.17×0 works
  8. Agricultural and Biological Sciences0.61×0 works
  9. Environmental Science0.47×0 works
  10. Health Professions0.38×0 works
  11. Materials Science0.29×0 works
  12. Social Sciences0.23×0 works
  13. Engineering0.18×0 works
  14. Business, Management and Accounting0.10×0 works

Who are the top researchers at Abiogen Pharma (Italy)?

Ranked on the quality score, Fabrizio Nannipieri, Leopoldo Della Ciana and Stefano Ceccanti lead among researchers whose main affiliation is Abiogen Pharma (Italy).

  1. 1 Fabrizio Nannipieri Italy · #995,922 worldwide 482 citations · 39 works
  2. 2 Leopoldo Della Ciana Italy · #1,746,190 worldwide 1.4k citations · 34 works
  3. 3 Stefano Ceccanti Italy · #5,577,427 worldwide 113 citations · 95 works
All ranked researchers at Abiogen Pharma (Italy)

What are the most cited papers from Abiogen Pharma (Italy)?

The most cited paper from Abiogen Pharma (Italy) is "Ru(bpy)3 Covalently Doped Silica Nanoparticles as Multicenter Tunable Structures for Electrochemiluminescence Amplification" (Simone Zanarini, Enrico Rampazzo, Leopoldo Della Ciana et al., 2009), with 168 citations. Next come "Enantioselective Fluorescence Sensing of Amino Acids by Modified Cyclodextrins: Role of the Cavity and Sensing Mechanism" (127) and "Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors" (109).

Most cited papers
#PaperReleasedCitations
1 Ru(bpy)3 Covalently Doped Silica Nanoparticles as Multicenter Tunable Structures for Electrochemiluminescence Amplification Simone Zanarini, Enrico Rampazzo, Leopoldo Della Ciana et al. · Journal of the American Chemical Society 22 Jan 2009 168
2 Enantioselective Fluorescence Sensing of Amino Acids by Modified Cyclodextrins: Role of the Cavity and Sensing Mechanism Sara Pagliari, Roberto Corradini, Gianni Galaverna et al. · Chemistry - A European Journal 16 Apr 2004 127
3 Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors Luigi di Filippo, Stefano Frara, Fabrizio Nannipieri et al. · The Journal of Clinical Endocrinology & Metabolism Open access 13 Apr 2023 109
4 Asymmetric Reactions Enabled by Cooperative Enantioselective Amino- and Lewis Acid Catalysis Pier Giorgio Cozzi, Andrea Gualandi, Simone Potenti et al. · Topics in Current Chemistry Open access 25 Nov 2019 103
5 Application of coumarin dyes for organic photoredox catalysis Andrea Gualandi, Giacomo Rodeghiero, Emanuele Della Rocca et al. · Chemical Communications Open access 2018 88
All 84 most cited papers, with filters and sorting

Which keywords describe research at Abiogen Pharma (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Cardiovascular Disease, Biosensors, Inflammation, Organic Synthesis, Transition Metal Complexes, Self-Assembly, Molecular Machines and aptamers.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Inflammation3▲ 3.1×20 topics
  2. Epidemiology2▲ 1.64×20 topics
  3. Cardiovascular Disease2▲ 5.8×11 topics
  4. Biosensors2▲ 9.8×3 topics
  5. Oxidative Stress2▲ 2.8×12 topics
  6. Nanoparticles2▲ 3.6×5 topics
  7. Organic Synthesis2▲ 21×2 topics
  8. Cancer2▲ 3.1×9 topics
  9. Transition Metal Complexes2▲ 36×2 topics
  10. Self-Assembly1▲ 9.9×4 topics
  11. Depression1▲ 4.8×4 topics
  12. Molecular Machines1▲ 30×2 topics
  13. DNA nanotechnology1▲ 32×1 topic
  14. aptamers1▲ 32×1 topic
  15. Breast Cancer1▲ 11×5 topics
  16. Electrochemical Methods1▲ 119×1 topic
  17. Food Safety1▲ 11×4 topics
  18. Quality of Life1▲ 2.3×7 topics
  19. Visible Light Photoredox Catalysis1▲ 119×1 topic
  20. Green Chemistry1▲ 9.5×3 topics
  21. Reactive Oxygen Species1▲ 5.7×6 topics
  22. UV Radiation1▲ 59×2 topics

Which research topics does Abiogen Pharma (Italy) publish most on?

By volume in 2022-now: Vitamin D Research Studies, Menopause: Health Impacts and Treatments, Nutrition, Genetics, and Disease and Spectroscopy Techniques in Biomedical and Chemical Research.

Vitamin D Research Studies1Vitamin D Research Studies: 1 fractional worksMenopause: Health Impact…0Menopause: Health Impacts and Treatments: 0 fractional worksNutrition, Genetics, and…0Nutrition, Genetics, and Disease: 0 fractional worksSpectroscopy Techniques in Biomedical and Chemical Research: 0 fractional worksCeliac Disease Research and Management: 0 fractional worksOsteoarthritis Treatment and Mechanisms: 0 fractional worksMuscle metabolism and nutrition: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksOrgan Transplantation Techniques and Outcomes: 0 fractional works
Pathology and Forensic MedicineEndocrinology, Diabetes and MetabolismGeneticsBiophysics6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Vitamin D Research Studies Pathology and Forensic Medicine 1 works
  2. 2 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Nutrition, Genetics, and Disease Genetics 0 works
  4. 4 Spectroscopy Techniques in Biomedical and Chemical Research Biophysics 0 works
  5. 5 Celiac Disease Research and Management Gastroenterology 0 works
  6. 6 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  7. 7 Muscle metabolism and nutrition Cell Biology 0 works
  8. 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  9. 9 Dermatology and Skin Diseases Dermatology 0 works
  10. 10 Organ Transplantation Techniques and Outcomes Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.6%not open48.4%

World: 40% of research is openly available.

with international co-authors30.3%domestic only69.7%

World: 18% is written across borders.

How has Abiogen Pharma (Italy)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Abiogen Pharma (Italy) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.000025%0.000050%0.000075%Abiogen Pharma (Italy)0.000063% in 2025200020102020

Fractional works of Abiogen Pharma (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Pisa

All research institutions in Pisa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Abiogen Pharma (Italy). Posts are plain text and can be reported.